Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Whooping cough--an increasing problem in Norway].

Susanne Gjeruldsen Dudman1, Marius Trøseid, Tom Øystein Jonassen

  • 1Mikrobiologisk avdeling, Akershus universitetssykehus, 1478 Lørenskog. susanne.gjeruldsen@ahus.no

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|January 28, 2006
PubMed
Summary

Whooping cough (pertussis) is increasing in Norway, affecting all age groups. Early macrolide treatment is key for milder symptoms and reduced contagiousness, with infants facing the highest risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vaccination of immunosuppressed patients.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same author

Long-term HIV-1 remission achieved through allogeneic haematopoietic stem cell transplant from a CCR5Δ32/Δ32 sibling donor.

Nature microbiology·2026
Same author

A newborn boy with fever and seizures.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same author

Vaccines at the Heart of Hepatitis Elimination: Insights From the ESCMID Study Group for Viral Hepatitis (ESGVH).

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Oral <i>Eikenella</i> as a potential new biomarker of symptomatic carotid atherosclerosis.

Journal of oral microbiology·2026
Same author

Efficacy, safety, pharmacokinetics, immunogenicity, and serum neutralizing activity of AZD7442 (tixagevimab-cilgavimab) in patients hospitalized with COVID-19: long-term results from the DisCoVeRy trial.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2025

Area of Science:

  • Infectious Diseases
  • Bacteriology
  • Public Health

Background:

  • Whooping cough (pertussis) incidence has risen in Norway, reaching 168/100,000 in 2004.
  • The disease is caused by the bacterium Bordetella pertussis.

Observation:

  • Transmission occurs via respiratory droplets, with family and school settings being common sources.
  • Typical symptoms include violent coughing fits; milder cases are seen in vaccinated or older individuals.
  • Infants are most vulnerable, experiencing higher rates of hospitalization, complications, and mortality.

Findings:

  • Diagnosis involves culture or PCR of nasopharyngeal secretions and serological antibody detection.
  • Macrolides are the recommended treatment, shortening symptom duration and contagiousness if initiated early.

Related Experiment Videos

  • Complications in adolescents and adults include pneumonia, rib fractures, and urinary incontinence.

    • Implications:

    • An additional vaccine booster for seven-year-old children was introduced in Norway in 2006 to control pertussis.
    • Understanding transmission dynamics and risk factors is crucial for effective public health interventions.
    • Prompt diagnosis and treatment are essential to mitigate severe outcomes, particularly in infants.